{
  "Disease": [
    {"role": "user", "content": "Please identify the \"Disease\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Disease\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: However , a 38 % remission rate has been recently reported in refractory MCL treated with temsirolimus , a mTOR inhibitor . Here we had the opportunity to study a case of refractory MCL who had tumor regression two months after temsirolimus treatment , and a progression - free survival of 10 months .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| MCL |\n| MCL (refractory) |\n| MCL (refractory) |\n\nExplanation:\n\n* MCL stands for Mantle Cell Lymphoma, which is a type of cancer.\n* Refractory MCL refers to Mantle Cell Lymphoma that has not responded to previous treatments.\n* Temsirolimus is a drug used to treat refractory MCL.\n\nTherefore, the three entities related to disease in the given paragraph are:\n\n1. MCL\n2. Refractory MCL\n3. Refractory MCL (second mention)"},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Disease\" and present the valid entities as a Markdown table with one column \"Disease\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "Sure, here's the updated table with only the entities that clearly refer to a disease:\n\n| Disease |\n| --- |\n| MCL |\n| Refractory MCL |\n\nExplanation:\n\n* MCL stands for Mantle Cell Lymphoma, which is a type of cancer.\n* Refractory MCL refers to Mantle Cell Lymphoma that has not responded to previous treatments.\n\nThe entity \"temsirolimus\" is a drug used to treat refractory MCL, but it is not a disease entity. Therefore, it has been removed from the table."}
  ],
  "Chemical": [
    {"role": "user", "content": "Please identify the \"Chemical\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Chemical\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: However , a 38 % remission rate has been recently reported in refractory MCL treated with temsirolimus , a mTOR inhibitor . Here we had the opportunity to study a case of refractory MCL who had tumor regression two months after temsirolimus treatment , and a progression - free survival of 10 months .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| Temsirolimus |\n| mTOR inhibitor |"},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Chemical\" and present the valid entities as a Markdown table with one column \"Chemical\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "Sure, here's the updated table with the valid chemical entities:\n\n| Chemical |\n| --- |\n| Temsirolimus |\n\nThe entity \"mTOR inhibitor\" is not a specific chemical entity, but rather a class of drugs that inhibit the mTOR pathway. Therefore, it is not included in the table."}
  ]
}